用一种旧疗法对抗一种新疾病：用于治疗新冠肺炎的康复期血浆 - Suppr

Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19.

作者信息

Rubin Rita

出版信息

JAMA. 2020 Jun 2;323(21):2114-2117. doi: 10.1001/jama.2020.7456.

DOI:10.1001/jama.2020.7456

PMID:32352484

Abstract

摘要

相似文献

Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19.

JAMA. 2020 Jun 2;323(21):2114-2117. doi: 10.1001/jama.2020.7456.

The resurgence of convalescent plasma therapy.

Lancet Haematol. 2020 May;7(5):e353. doi: 10.1016/S2352-3026(20)30117-4.

Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19?

Homeopathy. 2020 Aug;109(3):184-185. doi: 10.1055/s-0040-1714061. Epub 2020 Jul 9.

Convalescent Plasma: Promise for COVID-19 Pandemic.

J Coll Physicians Surg Pak. 2020 Jun;30(6):88. doi: 10.29271/jcpsp.2020.Supp1.S88.

Convalescent plasma is ineffective for covid-19.

BMJ. 2020 Oct 22;371:m4072. doi: 10.1136/bmj.m4072.

Evidence lags behind excitement over blood plasma as a coronavirus treatment.

Nature. 2020 Aug;584(7822):505. doi: 10.1038/d41586-020-02324-2.

The convalescent sera option for containing COVID-19.

J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.

Convalescent plasma to treat COVID-19.

Blood. 2020 Aug 6;136(6):654-655. doi: 10.1182/blood.2020007714.

Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.

Trials. 2020 Jun 8;21(1):499. doi: 10.1186/s13063-020-04422-y.

Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?

Transfus Apher Sci. 2020 Aug;59(4):102858. doi: 10.1016/j.transci.2020.102858. Epub 2020 Jun 27.

引用本文的文献

Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections.

Hum Vaccin Immunother. 2023 Dec 31;19(1):2209000. doi: 10.1080/21645515.2023.2209000.

Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2.

Cell Discov. 2023 Jan 6;9(1):2. doi: 10.1038/s41421-022-00510-2.

COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research.

Blood Rev. 2022 Jul;54:100931. doi: 10.1016/j.blre.2022.100931. Epub 2022 Jan 31.

A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.

Nat Commun. 2022 Jan 19;13(1):383. doi: 10.1038/s41467-022-28064-7.

Safety and Seroconversion of Immunotherapies against SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis of Clinical Trials.

Pathogens. 2021 Nov 24;10(12):1537. doi: 10.3390/pathogens10121537.

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections.

Life (Basel). 2021 Jul 23;11(8):734. doi: 10.3390/life11080734.

The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.

Pulmonology. 2021 Sep-Oct;27(5):423-437. doi: 10.1016/j.pulmoe.2021.03.008. Epub 2021 Apr 9.

Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.

Matched Cohort Study of Convalescent COVID-19 Plasma Treatment in Severely or Life Threateningly Ill COVID-19 Patients.

Open Forum Infect Dis. 2021 Jan 4;8(2):ofab001. doi: 10.1093/ofid/ofab001. eCollection 2021 Feb.

COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.

J Pathol. 2021 Jul;254(4):307-331. doi: 10.1002/path.5642. Epub 2021 Mar 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献